Deal Summary

Kestra Medical Technologies

$200,000,000

Non-dilutive financing

Pharmakon Advisors

Deal Notes:

To fortify balance sheet

Industry:

Healthcare

Role:

Manager

Event:

Recapitalization

Recent Deal Announcements